STOCK TITAN
  1. Home
  2. News
  3. KAYS

Kaya Holdings Inc - KAYS STOCK NEWS

Welcome to our dedicated news page for Kaya Holdings (Ticker: KAYS), a resource for investors and traders seeking the latest updates and insights on Kaya Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kaya Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kaya Holdings's position in the market.

News
Kaya Holdings (OTCQB:KAYS) Unveils "The Scared Mushroom(TM)", the First U.S.-Based Psilocybin Center to be Operated by a U.S. Public Company
Rhea-AI Summary
Kaya Holdings, Inc. announces progress on opening 'The Sacred Mushroom' Psilocybin Facilitation Center in Portland, Oregon, offering various treatment experiences and inviting interested parties to view the project presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.78%
Tags
none
-
News
Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game
Rhea-AI Summary
Kaya Holdings secures financing for psilocybin treatment center in Oregon
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.51%
Tags
none
-
News
Kaya Holdings (OTCQB:KAYS) Closes Additional Round of Non-Dilutive Bridge Financing Targeted to Complete The Sacred Mushroom(TM) Psilocybin Treatment Center
Rhea-AI Summary
KAYS has closed an additional round of bridge financing to complete its planned psilocybin treatment center in Portland, Oregon. The facility will operate under the name 'The Sacred Mushroom'. The total funds received from the bridge financing are $600,000, with $100K in short-term financing and $500K to be repaid from 10% of KAYS' revenues quarterly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.78%
Tags
none
News
Kaya Holdings (OTCQB:KAYS) Secures Site for The Sacred Mushroom(TM) Planned Psilocybin Treatment Center
Rhea-AI Summary
Kaya Holdings secures space for its psilocybin treatment center in Portland, Oregon. The facility will offer visitors access to microdosing café, private treatment rooms, and group session areas. The company aims to provide affordable relief for people with treatment-resistant mental health disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
none
-
News
Kaya Holdings, Inc.’s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
-
News
Kaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics Mind Care Clinics
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.38%
Tags
none
News
Kaya Holdings, Inc. (OTCQB:KAYS) Launches Fifth Dimension Therapeutics(TM) to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and address the Growing Multi-Billion Dollar Global Psychedelics Market
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
35.51%
Tags
none
-
News
Kaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
62.71%
Tags
none
-
News
Cannabis Company Kaya Holdings, Inc's Greek Joint Venture Receives Crucial Installation License for 50K Sq. Ft. Medical Cannabis Facility in Epidaurus, Greece
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.26%
Tags
none
News
Cannabis Company Kaya Holdings, Inc Acquires 50% of 2nd Medical Cannabis Project in Epidaurus, Greece
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
acquisition
Stock KAYS logo
Kaya Holdings Inc

OTC:KAYS

KAYS Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

KAYS Stock Data

787.13k
17.82M
19.65%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States
Fort Lauderdale

About KAYS

operating more than four decades, as of today, we at kaya are proud to be active in various sectors with 8 companies and more than 4.000 employees, each assuming the satisfaction of our guests & customers as the vital priority. this vision-driven approach of our team members is the key guidance for all our services. we at kaya know that we not only guarantee your satisfaction but also endeavor to contribute to the future of robust generations. hence, we take ourselves on a mission to become the pioneer of “the best” at all times by adding new challenges to our achievements in various sectors including hospitality, civil aviation, construction, retail, energy and agriculture. thanks to this motivation, we have the talent to create the synergy around these business lines that have become the pure source of our significant growth. being proud of every facility with our logo, we today not only accommodate more than 9.500 beds but also focus on international expansion for almost every busin